NFE2L2 and juvenile Huntington disease: Other studies carried out in rat models of Huntington’s disease (Túnez et al., 2006) and olfactory bulbectomy (Tasset et al., 2010) corroborate the antioxidant actions of rTMS, suggesting that it may be mediated through the Nrf2 pathway.